CDC25A and CDC25B, being oncogenes, are over-expressed in many different primary human cancers, such as head and neck cancer, poorly differentiated non-small cell lung cancer, advanced stage gastric cancer, non-Hodgkin's lymphomas, colon cancer, esophagus cancer, breast cancer, and ovarian cancer. This evidence concerns the gene CDC25B and gastric cancer.